How should bupropion (Wellbutrin), lamotrigine, olanzapine, and fluoxetine be used and dosed to treat an adult with bipolar II depression and comorbid ADHD?

Treatment Approach for Bipolar II Depression with Comorbid ADHD

For an adult with bipolar II depression and ADHD, prioritize mood stabilization with lamotrigine first, then add bupropion (Wellbutrin) for both residual depressive symptoms and ADHD, reserving olanzapine-fluoxetine combination for treatment-resistant cases.

Treatment Algorithm

Step 1: Establish Mood Stability with Lamotrigine

• Start lamotrigine as the foundational mood stabilizer for bipolar II depression
• Target dose: 100-250 mg daily (based on evidence showing mean effective dose of 125.6 mg) 1
• Lamotrigine specifically addresses both bipolar depression maintenance and has emerging evidence for ADHD symptoms in this population 1
• Critical caveat: Titrate slowly (typically 25 mg every 2 weeks) to minimize Stevens-Johnson syndrome risk

Step 2: Add Bupropion for ADHD and Residual Depression

Once mood is stabilized (sustained euthymia for at least 2-4 weeks):

• Bupropion extended-release 150-450 mg daily is the preferred first-line agent 2
• This medication addresses both ADHD symptoms (standardized mean difference -0.50 for symptom reduction) 3 and provides additional antidepressant effects
• Key advantage: Lower risk of manic switch compared to traditional stimulants in bipolar II disorder 2
• Start at 150 mg daily, increase to 300 mg after 1 week if tolerated

Step 3: Reserve Olanzapine-Fluoxetine for Treatment-Resistant Cases

If inadequate response after 8-12 weeks:

• Olanzapine 5 mg + fluoxetine 20 mg daily (FDA-approved combination) 4
• This combination showed efficacy specifically for bipolar I depression with mixed features (43.2% response rate) 5
• Important limitation: Olanzapine monotherapy is NOT indicated for bipolar depression 4
• Maximum safe doses: 18 mg olanzapine with 75 mg fluoxetine in adults 4

Critical Clinical Considerations

Diagnostic Precision Required

• Confirm ADHD diagnosis only during sustained euthymia - many bipolar symptoms mimic ADHD (distractibility, impulsivity, racing thoughts) 2
• If uncertain, treat mood disorder first and reassess ADHD symptoms after 2-3 months of mood stability

Medication Sequencing Rationale

The evidence strongly supports treating bipolar disorder before ADHD in comorbid cases 6. The 2002 AACAP guidelines explicitly state: "If major depressive disorder is the primary disorder or accompanied by very severe symptoms, the MDD should be the focus of treatment" 6. However, bipolar II depression is distinct from unipolar depression, requiring mood stabilization to prevent cycling.

Why This Specific Combination?

1. Lamotrigine: Only mood stabilizer with Level 1 evidence for bipolar II depression maintenance and emerging data for ADHD comorbidity 1
2. Bupropion: Dual benefit for ADHD and depression with lower manic switch risk than stimulants (3.8% vs higher rates with amphetamines) 2, 7
3. Olanzapine-fluoxetine: Reserved for resistant cases due to metabolic side effects (weight gain, dyslipidemia) 4

Avoid These Common Pitfalls

• Do NOT use stimulants first - risk of mood destabilization in bipolar I is well-established, and while bipolar II carries lower risk, mood stabilization should precede stimulant trials 2
• Do NOT use fluoxetine monotherapy - antidepressants alone in bipolar disorder risk cycling, though fluoxetine showed relatively low switch rates (3.8%) in bipolar II 7
• Do NOT use olanzapine alone for depression - it lacks FDA indication and evidence for bipolar depression as monotherapy 4

Monitoring Requirements

• Baseline and periodic monitoring: Weight, fasting glucose, lipid panel (especially if using olanzapine) 4
• Mood charting: Track for hypomanic/manic symptoms when adding bupropion or any ADHD medication
• ADHD symptom assessment: Use validated scales (e.g., ASRS) only after achieving mood stability

Alternative Considerations

If bupropion is contraindicated (seizure history, eating disorder):

• Consider atomoxetine as second-line ADHD treatment after mood stabilization 8
• Modafinil is a second-line option per CANMAT guidelines 2
• Long-acting stimulants (mixed amphetamine salts, methylphenidate) only in patients at "low risk for manic switch" with established mood stability 2

Treatment Timeline Expectations

• Lamotrigine: 4-8 weeks to reach therapeutic dose and assess mood response
• Bupropion: 2-4 weeks for ADHD symptom improvement 3
• Olanzapine-fluoxetine: 4-8 weeks for full antidepressant effect 5
• Total time to optimal regimen: 12-16 weeks minimum